|Articles|October 8, 2019
The management of Atopic Dermatitis Across the Generations
Are some doctors overlooking symptoms of new-onset atopic dermatitis (AD) among older patients? How do diagnostic workups for new-onset AD differ for with teens, adults, or the elderly compared to young children? Do recently developed systemic biologic therapies show promise? In this educational supplement, three physician experts discuss approaches to treating the chronic, relapsing disease.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Content
Latest CME
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5
